The Impact on Cognitive Health
Natural frequencies, like that of Schumann and the embryonic frequency, are the subject of increasing attention in the field of neuroscience. These frequencies have been associated with beneficial effects on the brain, in particular by improving neural connectivity, regulating brain activity and providing neuroprotection against inflammation. Scientific interest in these phenomena is based on studies that explore how exposure to these frequencies can potentially support cognitive function and improve the quality of life of people with neurodegenerative disorders or learning disabilities. This article includes extracts from studies detailing the impact of frequencies on aspects such as memory, attention, and neuroplasticity.
Improvement of neural connectivity: Schumann's frequency is associated with the alignment of brain waves, in particular alpha waves, which are linked to relaxation and vigilance. Increased synchronization of alpha waves could help stabilize cognitive function in people with neurodegenerative diseases such as Alzheimer's or Parkinson disease. Studies have shown that improving neuronal connectivity and reducing the imbalances in brain waves could slow the progression of certain cognitive symptoms associated with these diseases.
Neuroprotection and reduction in inflammation: Some research suggests that exposure to the frequencies of Schumann and embryonic can have a neuroprotective effect by reducing cerebral inflammation, which is often present in neurodegenerative diseases. By modulating the inflammatory response and promoting a more stable neuronal environment, these frequencies could help delay cell degeneration and improve the quality of life of patients.
Regulation of brain activity: attention disorders, such as ADHD, are often associated with an imbalance in brain waves, with an overactivity of certain frequencies (such as beta waves) and subactivity of others (like Alpha and TheTA waves). The use of Schumann's frequency can help rebalance these brain waves, promoting better concentration and attention control. Some neurofeedback therapies use frequencies close to 7.83 Hz to regulate brain activity in people with ADHD.
Improvement of memory and learning capacities: the frequencies of Schumann and embryonnaire could also improve memory and learning by facilitating the transition between states of consciousness Alpha and TheTA, associated with the learning and consolidation of the memory. By helping the brain to reach these states more coherently, these frequencies could support the processes of memorization and acquisition of new skills.
Studies in neuroscience: studies on the use of specific frequencies to treat cognitive disorders have shown that exposure to low frequencies can improve the regulation of brain waves and potentially reduce symptoms of neurocognitive disorders. For example, research published in Neuroscience Letters has shown that low -frequency transcranial magnetic stimulation could improve cognition in patients with neurodegenerative diseases.
Electromagnetic stimulation therapies: other research in electrotherapy and brain stimulation explored the use of frequencies like 2.28 Hz to positively influence cognitive functions. These studies suggest that such frequencies can modulate neuronal activity, improve connectivity between the brain regions involved in attention and learning, and provide support to patients with cognitive disorders.
Support for learning and memory: with regard to learning disabilities such as dyslexia, some studies explore the use of Schumann and embryonic frequencies to improve reading and understanding by modulation of Brain activity in the areas involved in language and sensory integration. Improving neuronal plasticity by exposure to these frequencies could also facilitate the creation of new neuronal connections, essential to overcome learning obstacles.
Current studies and future research projects: Several research projects and clinical studies are underway to assess the effectiveness of the frequencies of Schumann and embryonic in the care of patients with neurocognitive disorders. These studies include trials on the modulation of brain waves, the effects on stress and inflammation biomarkers, and long -term impacts on the quality of life of patients.